Mentoring the next generation: interview with Mike Romano
Attracting new talent to the material handling industry—and nurturing that talent—has long been a focus of Mike Romano's efforts, both in his own company and in his work with industry organizations.
Peter Bradley is an award-winning career journalist with more than three decades of experience in both newspapers and national business magazines. His credentials include seven years as the transportation and supply chain editor at Purchasing Magazine and six years as the chief editor of Logistics Management.
Earlier this year, MHI honored Mike Romano, president and CEO of material handling solution specialist Associated, with its first Young Professional Network Mentor Award. The award is given to an MHI member who promotes and encourages professional development in the industry.
MHI, a trade association for the material handling, logistics, and supply chain industry, said at the time it had established the award to recognize a member "who offers professional guidance, instills and nurtures talent, advocates for employees and their professional development, possesses a commitment to the company and its people, and serves as a positive and inspiring role model."
Judging by his record of service to the industry, Romano, a 35-year veteran of the material handling business, certainly fills that bill. He has been an active participant in industry organizations, serving on the Material Handling Equipment Distributors Association's (MHEDA) board of directors and executive committee, including a term as president. He has also served on the College-Industry Council of Material Handling Education (CICMHE) Foundation and MHI's Education Foundation board of directors.
He recently spoke to DCV Editorial Director Peter Bradley about his efforts to attract young talent to the material handling industry and then hold onto that talent.
Q: Tell me a little bit about the mentoring efforts for which you were recently recognized by MHI.
A: I've been in the industry since 1980, but around (the year) 2000, I realized there was a significant shortage of people available to bring into the industry. We recycle people in this industry. That doesn't promote new ideas and creative concepts. So, I made that part of my initiatives as president at MHEDA and formed a committee at MHEDA to address the issue. As we saw it, the problem was that we, as an industry, were fairly transparent to the academic community, to the consumer community, etc. We were kind of behind the scenes, so when kids got out of school, they didn't think about going into the material handling industry the way they might think about going into electronics or retail. That was the biggest part, the lack of visibility.
So we worked with MHI on an industry awareness initiative. It never got a lot of traction, but what it did was at least get people to realize there were two issues that the industry faced. Number one was the shortage of people. The second was the inverse relationship that existed between the price that we get for our services and the value that they provide. We really tried to promote both of those things through that initiative. When that fell by the wayside, we started taking a more micro approach at MHEDA. We started targeting schools to work with, and we asked MHI if we could get involved with CICMHE and sponsor a professor to try to build bridges with the academic community. We did that. MHEDA has continued to be involved with CICMHE.
We have coupled that initiative and our relationships through CICMHE to target schools that we could use as feeder schools, and we actually initiated a program where we started bringing professors and two of their top students to the MHEDA convention every year, which was great. It exposed members to the kind of talent that these schools were producing.
That was on an industry level. On a more micro level, we've done the same thing in our own company. We've developed partnerships with three schools in particular—Loyola Chicago, Robert Morris University - Illinois, and Northern Illinois University—over the last couple of years.
Now, schools and colleges are not the only ones we're working with. Half of our employees have technical backgrounds. We have a whole demographic, the baby boomers, that's retiring. There was a good cross section of blue- and white-collar workers in that generation. It's a different story with the newcomers entering the work force. The parents of those kids pushed them to go to college, which has resulted in a tremendous shortage of blue-collar workers. So we work with two trade schools toward the end of making them, first of all, aware of our industry. At least 80 percent of our new technicians today are from the trade schools. We develop our own talent from the ground up.
Q: The whole idea of attracting young people to the business was the first challenge, but then we have an industry that has a high turnover rate. How do you retain people?
A: Well, each one of them has to have a mentor who is responsible for making their on-boarding and their employment experience a successful one. You can't treat someone who is new to the industry, new to the business world, the same way you treat somebody who is 10 years in. It requires very special handling. Most importantly, the mentor has to be someone other than their boss. It has to be somebody who's going to take them under their wing and show them the way, show them the ropes, and be there to answer any questions and help them overcome any obstacles.
Q: Related to all this, you've been active for a very long time in MHEDA, MHI, CICMHE, and other groups. What drives you to that? Why do you think it's important for professionals to be involved in organizations like that?
A: I believe that giving back, sharing my ideas and best practices with others toward the end of making the industry better, will make each of our businesses better in the long run, because people will appreciate and place a higher value on what we do. The industry in many sectors is commoditized and we need to elevate it beyond that, because when people go to buy something commoditized, they just look for the lowest price. We have too much value to provide and we do provide too much value to be treated that way. So, by working together, not as one organization, but as an industry, I think we can improve our position in the eyes of our customers and by doing that, individually improve each of our organizations. That is my biggest driver. The second driver is, of course, the satisfaction of giving back to something that has provided very well for me and my family and an industry that I am proud of and that I want to see elevated to a higher level.
Q: Let me go back to your work with young people. Do you see much of a difference between the current generation of young people coming into the workplace and people from a generation ago with respect to what they expect from work and what they're looking for?
A: Sure. We have an internal education program that focuses on the four generations of workers currently in our work force and how managers need to understand each group's needs and wants and characteristics and treat them differently. So part of it is an education program.
As for the up-and-coming workers, we definitely see a difference. For instance, they're less focused on money than on quality of life. It's important to them to have time for themselves, personal time, and a good work/life balance. It is also important to them to have a well-defined career path. Sometimes, they want to start moving down that path too quickly and we need to slow them down and make sure they understand that experience is part of it.
Now, on the other hand, they are much more independent. They are desirous of being empowered to do a job, and they work well independently. Their technical skill is at a much higher level than we could have counted on in prior generations. So we just need to know all the pluses as well as be aware of some of the differences in attitude. There are things that we are used to doing that they may not be willing to do, like working 12-hour days to get a job done. They would rather come up with a way to work smarter and get the job done in eight hours. So it's a matter of just learning about them.
Q: Generally, you are optimistic about the kids who are coming up?
A: Absolutely. I think our only challenge is to provide a visible and sufficiently attractive career path to keep them longer term. That is probably the biggest obstacle because of their impatience, because they want to be managers tomorrow. We see that a lot.
For players in the drug distribution business, the countdown is on. In less than two months, every business involved in the pharmaceutical supply chain must be fully compliant with the Drug Supply Chain Security Act (DSCSA)—a 2013 law containing strict traceability requirements for the distribution of certain prescription drugs. Over the past decade, the DSCSA has been implemented in phases, but now the clock is running out. The law takes full effect on Nov. 27, barring any further adjustments or delays.
Among other measures, the DSCSA requires drug manufacturers to affix a unique product identifier, essentially a barcode, to every package so it can be tracked and traced during its journey through the supply chain. To thwart drug counterfeiters, the new law further requires wholesalers and drug dispensers to verify the validity of products they handle to assure they are genuine.
Is the pharmaceutical industry ready for all this? To find out, we spoke with Elizabeth Gallenagh, general counsel and senior vice president, supply chain integrity at the Healthcare Distribution Alliance(HDA), a national organization that represents U.S. health-care distributors. In addition to serving as HDA’s chief legal officer, Gallenagh is also the group’s primary expert on prescription drug traceability, supply chain safety and integrity, distributor licensure, and tax issues. She is a graduate of the George Mason University School of Law and George Washington University.
Gallenagh recently spoke with David Maloney, **{DC Velocity’}s group editorial director, about the enactment of DSCSA for an episode of the “Logistics Matters” podcast.
Q: First of all, can you tell us a little bit about the Healthcare Distribution Alliance?
A: Yes, the Healthcare Distribution Alliance, or HDA, is a national trade organization representing pharmaceutical distributors, also known as wholesalers. We have about 40 members that purchase drugs from manufacturers. They store the products in their warehouses and then fill orders for pharmacy customers throughout the country.
Q: The Drug Supply Chain Security Act will go into final effect in November. What’s the intent of the legislation?
A: The Drug Supply Chain Security Act—or as we call it, the DSCSA—is a law that was enacted in 2013. Its intent was to put together a national framework for drug supply chain security, essentially to enable a tighter, safer, more secure supply chain for the domestic U.S. market.
It involves all trading partners and ultimately will create an interoperable system that enables investigations by tracing a product with every transaction or sale of that product throughout the supply chain, down to the provider level.
Q: What are the law’s major requirements?
A: The law was actually phased in over a period of about 10 years. Many of the major requirements went into effect throughout that initial 10-year period—things like requirements mandating that manufacturers serialize their products and stipulating that trading partners only do business with other authorized trading partners. Authorized trading partners are defined as those that are duly licensed or registered with the Food and Drug Administration (FDA) or licensed by the states.
It also requires tracking of product with every transaction. A transaction is defined as a sale of the product, essentially from one authorized trading partner to another. And as we progress into the final phase, the law will also require serialized data, basically transaction information at the serial-number level that moves with the product through every transaction throughout the supply chain.
Q: You’ve said that the industry has had years to ramp up to comply with the law. Are our pharmaceutical supply chains ready for the final phase?
A: I think that’s still the $64,000 question. I can speak for our members, who have been doing everything in their power to get their own systems and processes ready to receive the serialized products and data, and then to transmit that serialized data with the product to their pharmacy customers.
That said, there are still some gaps in the system. We have been in a “stabilization” period that expires on Nov. 27. During this period, everybody has been testing and bringing product and data transactions live into production. I will tell you that many are ready, but there are still bugs that are being worked out as we race toward November.
I should also note that on Aug. 19, the HDA sent a letter to the FDA stating that “despite a concerted effort, some in the supply chain appear to remain short of reaching our joint goal of complete implementation.” In its letter, the group urged the FDA to “take immediate action to forestall potential disruptions to the drug supply chain and patient care that could stem from incomplete implementation of the enhanced drug distribution security (EDDS) requirements” and asked the agency to adopt “a phased, stepwise approach” to implementing the requirements in order to avoid disruptions to the movement of drugs through the supply chain.
Q: Will penalties be imposed on companies that fail to meet the deadline?
A: There will be penalties. But it’s important to note that the DSCSA is really about setting up the framework for tracking and tracing products—so that a manufacturer will only be permitted to sell its product downstream if it is a serialized product and the manufacturer can transmit the corresponding serialized data with the product. And then a distributor can only receive that product and purchase it if it has the corresponding data.
Q: Of course, this is only possible if you have the right technology in place to monitor and track drugs as they move through the supply chain. What kind of technologies are being deployed to make this possible?
A: The key to all of this is the barcode, which is mandated under the law in terms of the way that product is serialized. Everybody in the supply chain has to have the capability to utilize the barcode. If you’re a manufacturer, you have to incorporate that 2-D barcode with the serialized data into that product’s label. And that should already be in place under the first phases of the law.
Downstream partners will have to be able to read that barcode and import that data into their systems. This also enables verification of the product at the unit level.
In addition, we’re also deploying what we call EPCIS [a global data-sharing standard developed by the global standards organization GS1 that allows businesses to capture and share information about the movement and status of goods]. That is the backbone for getting all of this serialized data flowing to all of the requisite trading partners throughout the supply chain.
Q: As we learned during the push to distribute Covid-19 vaccines, a good number of pharmaceutical products must be temperature- or humidity-controlled. Will these new regulations help ensure that they’re properly handled as they move through the supply chain?
A: The DSCSA doesn’t speak specifically to temperature controls. However, there are other parts of the law [the overall Drug Quality and Security Act, which includes the DSCSA as well as the Compounding Quality Act] that do require those controls to be in place. That said, the DSCSA does require affected parties to do business with authorized trading partners. And in order to be an authorized trading partner, you have to adhere to temperature controls and safety rules for products, product handling, etc.
Q: Many of our pharmaceuticals are manufactured overseas, in China and India, for example. Do foreign manufacturers have to comply with DSCSA requirements?
A: If a foreign entity is producing product for use in the U.S. domestic market, the product has to be approved by the FDA. And it also has to meet DSCSA requirements.
Q: We hear a lot about counterfeit products infiltrating the drug supply chain. Will these new regulations reduce the number of counterfeits in the market?
A: We certainly hope so. All of this really started [as an effort to combat the rise in] counterfeit products and transactions back in the early 2000s. Obviously, the idea is to deter counterfeiters from infiltrating the U.S. drug supply chain. But really, what the law does is provide tools for the FDA and regulatory agencies to investigate suspect and illegitimate product, as well as tools that will enable the trading partners that are involved in the transactions to identify suspect product, flag it, quarantine it, investigate it, and deem it OK or deem it illegitimate based on their investigations.
So it really gives some investigatory and prosecutorial tools to the agencies. And it puts a process in place with the technology and serialization to pinpoint whether something is good product through verification with the manufacturer or through tracing of the product data that has accompanied the product throughout its journey through the supply chain.
Q: Drug prices in the U.S. are notoriously high compared with prices in many other countries. Will these new requirements add to the overall cost of supplying medication?
A: I haven’t seen any data that alludes to DSCSA compliance adding to drug costs. It’s an industry that’s built around efficiency, and so my sense is that [pharma industry players] probably have also built in plans over the last decade to absorb some of those costs. That said, the law also established a national tracking and tracing framework, where before we had a 50-state patchwork of regulations. So there would likely be some efficiencies gained from following a single, nationwide protocol, even though it’s a huge undertaking, versus doing it 50 different ways across the country.
Q: Now that DSCSA is nearing full implementation, how are your members feeling about the process?
A: Our members have been committed to this from the very beginning. We were very involved in negotiating on the legislation and pushing these concepts. We really have been working toward implementation from the get-go and throughout this entire 11-year period; we very much want to get to full implementation. But in the beginning, there may be some hiccups. We may hit a few bumps along the way.
A colleague of mine used to say, “We don’t know what we don’t know.” And I think that at each phase as we deploy new technologies and new processes, we will learn new ways to do things more efficiently. So we’re pushing hard toward November, and we are very hopeful.
Autonomous inventory management system provider Corvus Robotics is delivering drone technology for lights-out warehouse environments with the newest version of its Corvus One drone system, announced today.
The update is supported by an $18 million funding round led by S2G Ventures and Spero Adventures.
“Corvus Robotics fits our mission to invest in companies that truly transform the way business is conducted,” Marc Tarpenning, co-founder of Tesla and partner at Spero Ventures, said in a press release Tuesday. “Other than a landing pad, its drone-powered system requires no infrastructure, is quick and easy to deploy, and cost-effective to manage. It literally merges with the existing warehouse environment.”
Corvus Robotics’ drone-based inventory management system uses computer vision and generative AI to understand its environment, flying autonomously in both very narrow aisles—a minimum width of 50 inches—and in very wide aisles. It uses obstacle detection to operate safely in warehouses and features an advanced barcode scanning system that can read any barcode symbology in any orientation placed anywhere on the front of cartons or pallets, according to the company.
The lights-out feature is already in use at customer locations.
“Being able to run inventory checks 24/7 without operator assistance has been a game changer,” Austin Feagins, senior director of solutions at third-party logistics services (3PL) provider Staci Americas, said in the release. “The lights-out capability in the Corvus One system allows our inventory teams to correct discrepancies off-shift and pre-shift before production starts each day, limiting fulfillment delays and production impacts.”
Demand for warehouse and industrial space continued to slump in the third quarter as the overall national industrial vacancy rate edged higher, climbing 30 basis points (bps) to 6.4%, according to the latest research by Cushman & Wakefield.
Although vacancy rose again, it increased by the lowest quarterly gain in vacancy since Q4 2022. The primary cause of the rising empty space was “vacant speculative deliveries,” as developers flooded the market, the report said.
“Industrial vacancy rates remain below the 10-year pre-pandemic average of 7% as new supply slowed and overall absorption remained soft, but positive,” Jason Price, Senior Director, Americas Head of Logistics & Industrial Research, said in a release. “We expect that net absorption will more than double in 2025 as leasing activity accelerates with greater economic certainty.”
Through the first three quarters of 2024, the strongest absorption totals of new real estate were seen in Dallas/Ft. Worth at 18.8 million square feet (msf), Houston at 17 msf, Phoenix at 15.1 msf, and Savannah at 7.4 msf. Conversely, the Los Angeles, New Jersey, Oakland/East Bay, Reno, Seattle, and Portland markets have yielded the highest amounts of negative absorption year to date.
Speculative developments continue to dominate the delivery landscape, accounting for 83% of the YTD new supply total. Expect Q4 deliveries to moderate a bit further nationwide as the construction pipeline has dwindled substantially over the last two years.
The average asking rental rate for industrial space exceeded the $10 per square foot (psf) level for the first time in history at the close of Q3 at $10.08 psf. This marked a 4.3% rise year-over-year as some markets continue to see rents tick higher despite softer fundamentals than the past three years.
“Industrial construction is in the final stages of adjusting to the more normalized levels of demand and absorption and we expect to see markets stabilize in 2025,” said Price. “The pipeline has shrunk to a low (309.3 msf) not seen since year-end 2018 and will continue to dissipate into early next year as construction starts remain muted. We anticipate demand reaccelerating in the second half of next year amid softer delivery totals, coupled with healthy leasing totals.”
E-commerce giant Amazon is in the process of hiring 250,000 people across the U.S. as it heads into the holiday season, saying it will pay all seasonal employees at least $18 per hour and provide full-time hires with health care from the first day on the job.
The positions include full-time, part-time, and seasonal roles across the company’s customer fulfillment and transportation operations in the U.S., according to a blog post by Sandy Gordon, Amazon’s vice president, Global Operations Employee Experience.
The cloud-based solution, now called QAD Advanced Scheduling, optimizes production decisions by determining what products to make on each production line in the best possible sequence to minimize changeovers, optimize inventory, and align cost and service goals.
According to Santa Barbara, California-based QAD, manufacturers seek technology to become more efficient, agile and resilient in their pursuit of better competitiveness and profitability. The firm says its platform helps in these areas by scheduling related products together, in the best sequence, with visibility to inventories, capacity, product attributes and changeover costs. This improves the synchronization of manufacturing processes, resource utilization and on-time delivery, while also helping to reduce inventory levels and waste.
Laguna Beach, California-based Phenix Software Inc. originated from Zinata Inc. seven years ago after identifying that customers were experiencing major performance loss due to suboptimal changeovers and inventory levels, with no suitable tool to sustain the gains made with existing scheduling solutions. Committed to continuing to provide the best scheduling solutions available, Zinata has since become a QAD distributor to sell, support, and implement the product as a partner.